41 results for "Tsiatis, Anastasios"
Showing 21–40 · 1.03 seconds · RSS
-
Journal Article Full text
Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: A principled yet flexible approach
There is considerable debate regarding whether and how covariate adjusted analyses should be used in the comparison of treatments in randomized clinical trials. Substantial baseline covariate information is routinely collected in such trials, and one goal of adjustment is to exploit covariates…
-
Journal Article Full text
Using Decision Lists to Construct Interpretable and Parsimonious Treatment Regimes
A treatment regime formalizes personalized medicine as a function from individual patient characteristics to a recommended treatment. A high-quality treatment regime can improve patient outcomes while reducing cost, resource consumption, and treatment burden. Thus, there is tremendous interest in…
-
Journal Article Full text
Optimal treatment regimes for survival endpoints using a locally-efficient doubly-robust estimator from a classification perspective
A treatment regime at a single decision point is a rule that assigns a treatment, among the available options, to a patient based on the patient’s baseline characteristics. The value of a treatment regime is the average outcome of a population of patients if they were all treated in accordance to…
-
Journal Article Full text
Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions
A dynamic treatment regime is a list of sequential decision rules for assigning treatment based on a patient’s history. Q- and A-learning are two main approaches for estimating the optimal regime, i.e., that yielding the most beneficial outcome in the patient population, using data from a clinical…
-
Journal Article Full text
A Robust Method for Estimating Optimal Treatment Regimes
A treatment regime is a rule that assigns a treatment, among a set of possible treatments, to a patient as a function of his/her observed characteristics, hence “personalizing” treatment to the patient. The goal is to identify the optimal treatment regime that, if followed by the entire population…
-
Journal Article Full text
Interpretable Dynamic Treatment Regimes
Precision medicine is currently a topic of great interest in clinical and intervention science. A key component of precision medicine is that it is evidence-based, i.e., data-driven, and consequently there has been tremendous interest in estimation of precision medicine strategies using…
-
Journal Article Full text
Response to Reader Reaction to “A Robust Method for Estimating Optimal Treatment Regimes”
-
Journal Article Full text
Estimating Optimal Treatment Regimes from a Classification Perspective
A treatment regime maps observed patient characteristics to a recommended treatment. Recent technological advances have increased the quality, accessibility, and volume of patient-level data; consequently, there is a growing need for powerful and flexible estimators of an optimal treatment regime…
-
Journal Article Full text
Mixed model analysis of censored longitudinal data with flexible random-effects density
Mixed models are commonly used to represent longitudinal or repeated measures data. An additional complication arises when the response is censored, for example, due to limits of quantification of the assay used. While Gaussian random effects are routinely assumed, little work has characterized the…
-
Journal Article Full text
Discussion of “Combining Biomarkers to Optimize Patient Treatment Recommendation”
-
Journal Article Full text
Q- and A-learning Methods for Estimating Optimal Dynamic Treatment Regimes
In clinical practice, physicians make a series of treatment decisions over the course of a patient’s disease based on his/her baseline and evolving characteristics. A dynamic treatment regime is a set of sequential decision rules that operationalizes this process. Each rule corresponds to a…
-
Journal Article Full text
Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial
The Superior Yield of the New Strategy of Enoxaparin, Revascularization, and GlYcoprotein IIb/IIIa inhibitors (SYNERGY) was a randomized, open-label, multicenter clinical trial comparing 2 anticoagulant drugs on the basis of time-to-event endpoints. In contrast to other studies of these agents, the…
-
Journal Article Full text
On Random Sample Size, Ignorability, Ancillarity, Completeness, Separability, and Degeneracy: Sequential Trials, Random Sample Sizes, and Missing Data
The vast majority of settings for which frequentist statistical properties are derived assume a fixed, a priori known sample size. Familiar properties then follow, such as, for example, the consistency, asymptotic normality, and efficiency of the sample average for the mean parameter, under a wide…
-
Journal Article Full text
Properties of Estimators in Exponential Family Settings with Observation-based Stopping Rules
Often, sample size is not fixed by design. A key example is a sequential trial with a stopping rule, where stopping is based on what has been observed at an interim look. While such designs are used for time and cost efficiency, and hypothesis testing theory has been well developed, estimation…
-
Journal Article Full text
Estimation After a Group Sequential Trial
Group sequential trials are one important instance of studies for which the sample size is not fixed a priori but rather takes one of a finite set of pre-specified values, dependent on the observed data. Much work has been devoted to the inferential consequences of this design feature. Molenberghs…
-
Journal Article Full text
Assessing the Causal Effect of Organ Transplantation on the Distribution of Residual Lifetime
Because the number of patients waiting for organ transplants exceeds the number of organs available, a better understanding of how transplantation affects the distribution of residual lifetime is needed to improve organ allocation. However, there has been little work to assess the survival benefit…
-
Journal Article Full text
Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy
A personalized treatment strategy formalizes evidence-based treatment selection by mapping patient information to a recommended treatment. Personalized treatment strategies can produce better patient outcomes while reducing cost and treatment burden. Thus, among clinical and intervention…
-
Journal Article Full text
Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure
BACKGROUND: Implantable cardioverter defibrillator (ICD) therapy significantly prolongs life in patients at increased risk of sudden cardiac death from depressed left ventricular function. However, it is unclear whether this increased longevity is accompanied by deterioration in quality of life…
-
Journal Article Full text
Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation
Rationale: Lung transplantation is an accepted and increasingly employed treatment for advanced lung diseases, but the anticipated survival benefit of lung transplantation is poorly understood. Objectives: To determine whether and for which patients lung transplantation confers a survival benefit…
-
Journal Article Full text
Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials
To speed the development of vaccines against SARS-CoV-2, the United States Federal Government has funded multiple phase 3 trials of candidate vaccines. A single 11-member data and safety monitoring board (DSMB) monitors all government-funded trials to ensure coordinated oversight, promote…